Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,704 | -12,582 | -43,285 | -32,745 | -22,976 |
| Depreciation Amortization | 44 | 1 | -16 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,053 | 1,761 | 1,207 | 1,697 | 3,233 |
| Other Working Capital | 5,205 | 2,177 | 4,394 | 4,796 | 4,970 |
| Other Operating Activity | -3,540 | -525 | 1,635 | -69 | -2,528 |
| Operating Cash Flow | $-26,942 | $-9,168 | $-36,065 | $-26,321 | $-17,301 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,049 | -9,049 | -46,250 | N/A | N/A |
| Purchase Of Investment | 29,000 | 16,000 | N/A | N/A | N/A |
| Investing Cash Flow | $19,951 | $6,951 | $-46,250 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 113,713 | 194 | 42,941 | 42,870 | 21 |
| Other Financing Activity | 0 | 0 | 20,000 | 20,000 | 0 |
| Financing Cash Flow | $113,713 | $194 | $62,941 | $62,870 | $21 |
| Beginning Cash Position | 39,165 | 39,165 | 58,539 | 58,539 | 58,539 |
| End Cash Position | 145,887 | 37,142 | 39,165 | 95,088 | 41,259 |
| Net Cash Flow | $106,722 | $-2,023 | $-19,374 | $36,549 | $-17,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,942 | -9,168 | -36,065 | -26,321 | -17,301 |
| Free Cash Flow | -26,942 | -9,168 | -36,065 | -26,321 | -17,301 |